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Abstract
Background: The first step in glucose metabolism is conversion of glucose to glucose 6-phosphate (G-6-P) by hexokinases
(HKs), a family with 4 isoforms. The two most common isoforms, HKI and HKII, have overlapping tissue expression, but
different subcellular distributions, with HKI associated mainly with mitochondria and HKII associated with both
mitochondrial and cytoplasmic compartments. Here we tested the hypothesis that these different subcellular distributions
are associated with different metabolic roles, with mitochondrially-bound HK’s channeling G-6-P towards glycolysis
(catabolic use), and cytoplasmic HKII regulating glycogen formation (anabolic use).
Methodology/Principal Findings: To study subcellular translocation of HKs in living cells, we expressed HKI and HKII linked
to YFP in CHO cells. We concomitantly recorded the effects on glucose handling using the FRET based intracellular glucose
biosensor, FLIPglu-600 mM, and glycogen formation using a glycogen-associated protein, PTG, tagged with GFP. Our results
demonstrate that HKI remains strongly bound to mitochondria, whereas HKII translocates between mitochondria and the
cytosol in response to glucose, G-6-P and Akt, but not ATP. Metabolic measurements suggest that HKI exclusively promotes
glycolysis, whereas HKII has a more complex role, promoting glycolysis when bound to mitochondria and glycogen
synthesis when located in the cytosol. Glycogen breakdown upon glucose removal leads to HKII inhibition and dissociation
from mitochondria, probably mediated by increases in glycogen-derived G-6-P.
Conclusions/Significance: These findings show that the catabolic versus anabolic fate of glucose is dynamically regulated
by extracellular glucose via signaling molecules such as intracellular glucose, G-6-P and Akt through regulation and
subcellular translocation of HKII. In contrast, HKI, which activity and regulation is much less sensitive to these factors, is
mainly committed to glycolysis. This may be an important mechanism by which HK’s allow cells to adapt to changing
metabolic conditions to maintain energy balance and avoid injury.
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Introduction
Upon entering the cell, glucose is phosphorylated to glucose-6-
phosphate (G-6-P), which is used catabolically in glycolysis, or
anabolically in glycogen synthesis and lipid synthesis via the
pentose phosphate shunt. In both cases, this first step is catalyzed
by hexokinases (HKs), which comprise a family of four isoforms.
HKI and HKII are the most abundant isoforms, with HKI (‘‘the
brain HK’’) ubiquitous in most tissues but especially brain and red
blood cells [1,2] where glycolysis plays a critical role in energy
production. In contrast, HKII (‘‘the muscle HK’’) is found
primarily in insulin-sensitive tissues such as adipocytes and adult
skeletal and cardiac muscle, where it accounts for 80% of total HK
activity [3]. At birth and after weaning, the latter tissues switch
from expression of GLUT1 and HKI, to GLUT4 and HKII. The
expression of GLUT4 and HKII coincides with the development
of insulin sensitivity as muscle switches from a straight carbohy-
drate to a mixed fat-carbohydrate diet [4]. In adult muscle, fatty
acids as well as glucose and glycogen are available as substrates to
support oxidative metabolism [5].
G-6-P facilitates glycogen synthesis by reciprocally activating
glycogen synthase (GS) and inhibiting glycogen phosphorylase
(GP) [6,7], and possibly by stimulating translocation of HK from
mitochondria to the cytoplasm. In liver cells where glycogen
synthesis is driven by glucokinase (GK or HKIV) rather than HKI,
G-6-P stimulates glycogen synthesis by causing a redistribution of
GK and GS to the cell periphery [8]. These data support the idea
of compartmentalized metabolic channeling, with HKI feeding
glycolysis, and HKII and HKIV feeding glycogen synthesis.
The idea that differing subcellular locations of HKI and HKII
are important was postulated by Wilson when he stated that ‘‘the
Type I isozyme bound to actively phosphorylating mitochondria
facilitates introduction of glucose into glycolysis, with the final
stages of glucose metabolism occurring in the mitochondria. In
contrast, Type II and to some extent Type III isozymes serve
primarily anabolic function to provide G-6-P for glycogen
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synthesis or lipid synthesis via the pentose phosphate pathway’’
(see review [9]). However, it was not clear at that time how
independent was the anabolic function of the Type II isozyme and
binding to mitochondria were related. Since then, Wilson and
others [10,11,12,13,14,15,16,17,18] have shown that the interac-
tion of HKs with mitochondria is not static, but is regulated by
factors such as glucose, G-6-P and kinases such as Akt and GSK-3.
Thus, a picture is emerging that HKII may play a dual role:
channeling G-6-P into the glycogen and the pentose phosphate
pathways when localized in the cytoplasm, and preferentially
shuttling G-6-P to glycolysis and oxidative phosphorylation when
bound to mitochondria [19]. In contrast, HKI generally facilitates
glycolysis; although under some specific non-physiological condi-
tions may contribute to glycogen synthesis [20].
HKI and HKII are inhibited allosterically by their product, G-
6-P, and this sensitivity to G-6-P decreases when HKs are bound
to mitochondria [21,22]. Physiological levels of orthophosphate
(Pi) counter the G-6-P inhibition of HKI [2,23,24], but not HKII.
In fact, Pi may cause further HKII inhibition. Based on these
observations, Wilson [9] suggested that ‘‘reciprocal changes in
intracellular levels of G-6-P and Pi are closely associated with
cellular energy status, and that the response of HKI to these
effectors adapts it for catalytic function, introducing glucose into
glycolytic metabolism. In contrast, HKII serves primarily anabolic
functions.’’
In the present study, we have expressed HKI and HKII tagged
with YFP in Chinese Hamster Ovary (CHO) cells to track their
subcellular location in real time and their mobilization in response
to substrates. Concomitantly, we measured changes in intracellular
glucose using a genetically-encoded intracellular glucose biosensor,
FLIPglu-600 mM, which undergoes changes in FRET upon
binding glucose [25] and assessed glycogen formation, also in live
cells, using a glycogen targeting protein, PTG, tagged with GFP.
In this study our goal was three-fold: 1) To further investigate the
roles of HKI and HKII in directing the metabolic fate of glucose
towards catabolic versus anabolic uses; 2) To assess how the
metabolic roles of HKI and HKII are related to their subcellular
localization; 3) To determine the signaling pathways regulating
subcellular distributions of HKI and HKII. Our findings support
the hypothesis that in response to changes in glucose, subcellular
translocation of HKII dynamically directs the metabolic fate of
glucose between catabolic (glycolysis) and anabolic (glycogen
synthesis and pentose phosphate shunt) uses, while HKI remains
associated with mitochondria to promote glycolysis. Factors such
as G-6-P and Akt play a central role in the regulation of HKII
activity and localization in response to changes in glucose.
Results
HK interaction with mitochondria and translocation to
the cytosol
To test the hypothesis that HKI interacts preferentially with
mitochondria to facilitate entry of G-6-P into the glycolytic
pathway, while HKII translocates into the cytosol to channel G-6-
P into the glycogen formation pathway, we carried out two types
of optical imaging experiments in CHO cells and HEK293 cells.
In the first, we linked YFP to the C terminus of HKI or HKII
(HKI-YFP and HKII-YFP) to track subcellular location. In the
second, we used a genetically-encoded low affinity intracellular
glucose sensor Flipglu-600 mM to monitor intracellular glucose
metabolism. In Fig. 1A, data obtained with HKI-YFP demon-
strates that HKI is bound to mitochondria with little or no
fluorescence found in the cytosol. Co-labeling with HKI-CFP and
MitoTracker-YFP (Fig. S1) supports the interpretation that HKI,
even when overexpressed, is predominantly bound to mitochon-
dria. In contrast, the distribution of HKII-YFP showed both
mitochondrial labeling and diffuse fluorescence in the cytoplasm
(Fig. 1C). To further characterize the interaction of HKs with
mitochondria, we cotransfected HKI-YFP together with wild-type
(wt) HKII (ratio 1:3), and conversely, HKII-YFP together with wt
HKI (ratio 1:3). HKII did not displace HKI-YFP from
mitochondria (Fig. 1B), while HKII-YFP was no longer associated
with mitochondria in the presence of excess HKI (Fig. 1D). These
data suggest that HKI has a strong affinity for a mitochondria-
binding site which cannot be easily displaced by HKII. In contrast,
HKII binding to mitochondria was much weaker and readily
displaced by excess HKI.
Effects of hexokinase overexpression in CHO cells
transfected with GLUT1
Next, we investigated how HKI and HKII affect glucose
metabolism by expressing a genetically encoded low affinity
intracellular glucose sensor Flipglu-600 mM in native CHO cells.
CHO cells express low levels of glucose transporters (GLUT),
however, they have low rates of glucose uptake and metabolism
compared to muscle cells [26]. Thus we overexpressed GLUT1 or
GLUT4, to increase glucose uptake (Figs S2 and S3). GLUT
overexpression both improved FRET signals and, facilitated
glycogen synthesis, which is activated by high intracellular glucose.
To characterize intracellular glucose handling, we used the GLUT
inhibitor Cyto B (20 mM) to block GLUT-sensitive transmem-
brane glucose transport. We had previously shown that in native
CHO cells, exposure to Cyto B prior to the addition of glucose
fully blocked subsequent glucose uptake [26]. In contrast, Cyto B
had almost no effect on the rate of glucose clearance following
glucose removal (Fig. S3A [1] vs. Fig. S3A [2]). The latter
observation suggests that glucose metabolism, rather than glucose
efflux, dominates glucose clearance in native CHO cells with a
slow rate of glucose transport (td= 33 s). On the other hand, in
CHO cells overexpressing GLUT1 (Fig. S3B [4]), with a high rate
of glucose transport (uptake half-time 3.5 s), Cyto B markedly
slowed the rate of glucose clearance upon glucose removal,
indicating that in CHO cells overexpressing GLUT1, glucose
efflux, rather than glycolysis, is the dominant factor regulating
glucose clearance. Together, these observations indicate that in
CHO cells overexpressing GLUT1 or GLUT4, glucose clearance
is dominated by glucose efflux via GLUTs rather than glucose
utilization by glycolysis. Thus, to study the metabolic fate of
glucose in CHO cells overexpressing GLUTs, subsequent
experiments were performed in the presence of Cyto B to block
glucose efflux following glucose removal.
Data in Fig. 2, obtained with and without HK overexpression,
show how expression of HKs alters the rate of glucose clearance
during glucose removal in the presence of Cyto B. Panels B and D
show that HKI overexpression decreased the average half-time of
glucose clearance (t1/2) from 114612 s to 7267 s (n = 9) (Fig. 2D).
In contrast, HKII overexpression (panels C and D) prolonged the
half-time to 217+/220 s (n = 9). Panels E and F show the
distribution of overexpressed HKI or HKII in CHO cells. These
data clearly demonstrate that increased HKI activity, which is
primarily associated with mitochondria, increases glucose metab-
olism, while increased HKII activity, which is found at least in part
in the cytosol, slows glucose metabolism.
To further assess the role of endogenous HKI and HKII in
glucose clearance we transfected CHO cells with 30 to 40 nM of
HKI or HKII siRNA. Knockdown of either HKI or HKII caused
a decrease in the rate of glucose clearance (Fig S4). These results
are consistent with our finding from RT-PCR analysis that the
HK Localization and Glucose Fate
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levels of endogenous HKI and HKII are very similar in CHO
cells.
Glycogen-derived G-6-P mediates glucose-dependent HK
inhibition
We hypothesized that when HKII is overexpressed, the
prolonged t1/2 of glucose clearance following a glucose pulse is
related to glycogen synthesis, which occurs during the glucose
pulse. Thus, when glucose is removed at the end of the pulse, the
cell mobilizes the newly synthesized glycogen for glycolysis, rather
than metabolizing the residual intracellular glucose. This expla-
nation is plausible only if glycogen mobilization also inhibits HK
enzymatic activity, such that the conversion of residual intracel-
lular glucose to G-6-P is suppressed. Since glycogenolysis involves
production of G-6-P, which inhibits HKs [21,22], we postulated
that elevated G-6-P levels during glycogenolysis might be
responsible for inhibiting HK activity, so that intracellular glucose
clearance is delayed. Consistent with this hypothesis, Fig. 3A
shows after a 30 s exposure to glucose (Fig. 3A [2]), glucose
clearance upon removing extracellular glucose (in the presence of
Cyto B) was rapid, and occurred at a rate similar to that observed
in the absence of GLUT overexpression. However, after a 75 s
exposure to 10 mM glucose (Fig. 3A [1]), to allow more time for
glycogen synthesis, glucose clearance by metabolism was delayed,
occurring very slow initially, followed by rapid clearance similar to
that after the short exposure to glucose. The t1/2 increased on
average from 88614 s after a 30 s exposure to glucose, to
285629 s (n = 15) after a 75 s exposure. In contrast, exposure to
1 mM extracellular glucose for several minutes, which increased
intracellular glucose level by less than half compared to 10 mM
glucose, did not cause a delay in glucose metabolism (Fig. 3B [4]
and [5]).
To test this hypothesis further, we imaged glycogen stores
directly by using probes linking either mCherry or GFP to PTG
and GL, both of which are part of the family of glycogen targeting
subunits of PP-1 [27]. CHO cells were transfected with one of
these probes, either with or without GLUT1 co-transfection. One
day after transfection, cells were incubated for 2 to 3 hours in the
absence of glucose to deplete glycogen stores. In the absence of
GLUT1 overexpression, some CHO cells exhibited dim homog-
Figure 1. Subcellular distribution of HKI and HKII linked to YFP in CHO cells. In the left panel HKI-YFP is expressed alone (A) or with HKII (B)
(ratio 1:3). In this case HKI-YFP is bound to mitochondria and is not displaced by overexpressed HKII. In the right panel HKII-YFP is expressed alone
and shows a mixed distribution between mitochondria and cytosol (C). In this case overexpression of HKI with HKII-YFP (ratio 1:3) prevents HKII-YFP
interaction with mitochondria (D). Similar subcellular distribution of HKI-YFP and HKII-YFP was observed in HEK293 cells.
doi:10.1371/journal.pone.0017674.g001
HK Localization and Glucose Fate
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enous fluorescence, while others had a few small and bright
punctuate deposits (Fig. 4A). After re-addition of glucose (10 mM)
for 30–60 min, the number, size and brightness of small glycogen
deposits began to increase. This phenomenon intensified over
24 hrs, until the deposits fused and partially filled the cell (Fig. 4C).
After a two hour exposure, removal of glucose resulted in a rapid
disappearance of glycogen deposits (Fig. 4B). With overexpression
of GLUT1, the rate of appearance of glycogen dramatically
increased, such that small deposits were observed within a few
minutes of exposure to 10 mM glucose (Fig. 4D). Thus, in CHO
cells overexpressing GLUT1, the rates of glycogen synthesis and
depletion are rapid enough to plausibly support our hypothesis
that relatively short glucose pulses could induce enough glycogen
synthesis to progressively delay the t1/2 of glucose clearance
following glucose removal.
The effects of PTG overexpression on the t1/2 of glucose
clearance following glucose removal are shown in Fig. 5. In
CHO cells transfected with PTG alone, PTG had no effect on
the t1/2 of glucose clearance (Fig. 5C), even after prolonged
exposure to glucose, which we attributed to intracellular glucose
never reaching an adequate level to induce glycogen synthesis (as
indicated by a low FRET ratio). However, in CHO cells
transfected with both GLUT1 and PTG, the lag phase was
pronounced after even a brief exposure to 10 mM glucose
(Fig. 5B). Thus, PTG, which stimulates glycogen synthesis by
facilitating the interaction of the regulatory enzyme PP-1
(protein phosphatase-1) with GS, GP and phosphorylase kinase,
leads to greater glycogen synthesis during brief exposures to
10 mM glucose. According to our hypothesis, this elevates G-6-P
levels for longer after glucose removal and delays glucose
clearance.
In summary, these data are consistent with removal of glucose
causing a switch from glycogen synthesis to glycogen breakdown,
thereby increasing G-6-P which blocks the utilization of glucose
by mitochondria-bound HK, in effect diverting G-6-P to
glycolysis.
Figure 2. Effects of HKI and HKII on glucose utilization in CHO cells. These data illustrates how overexpression of HKI (Panel B) and HKII
(Panel C) affects glucose clearance measured in the presence of CytoB. Comparison of A and B indicates that HKI increases the rate of glucose
clearance and thus metabolism, while comparison of A and C demonstrates that HKII has the opposite effect and decreases this rate. Panel E and F
show images similar to those in Fig. 1, which illustrate once more the interaction of HKI-YFP with mitochondria and the differential distribution of
HKII-YFP, these differential distribution can be correlated with the glucose clearance data in B and C, respectively. The bar graph in D quantifies these
data.
doi:10.1371/journal.pone.0017674.g002
HK Localization and Glucose Fate
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Regulation of the metabolic fate of glucose by the
subcellular distribution of HK
The observations so far indicate that HK1 overexpression
affects catabolism, accelerating the t1/2 of glucose clearance,
whereas HKII overexpression is anabolic, delaying the t1/2 by
promoting glycogen synthesis, with subsequent inhibition of HK
by glycogenolysis when extracellular glucose is removed. To
determine how these metabolic roles are related to the subcellular
localization of HKI and HKII, we studied the effects of
extracellular glucose on subcellular HK distribution in CHO
cells overexpressing HKI or HKII linked to YFP. Whether the
cells were incubated in the presence or absence of glucose
(10 mM), HKI-YFP always remained associated with mitochon-
dria, and addition or removal of glucose had no effect on its
location (n = 10) (Fig. 6A). In contrast, the subcellular distribution
of HKII-YFP was sensitive to extracellular glucose. In the
presence of glucose, a large fraction of HKII was bound to
mitochondria, and upon removal of extracellular glucose, HKII
rapidly translocated to the cytosol with a time constant averaging
8.5 min (n = 12) (Fig. 6B and 6C1). This effect was fully
reversible, such that upon re-addition of glucose, HKII re-
associated with mitochondria with a time constant of 15.5 min
(n = 4) (Fig. 6C2). These data support the hypothesis that HKI
binds strongly to mitochondria, while the distribution of HKII
between cytoplasm and mitochondria is labile, dynamically
regulated by glucose availability.
To evaluate the functional consequences of HKII redistribution
on glucose metabolism, cells were subjected to a 20 to 30 min pre-
incubation in the absence of glucose to maximize dissociation of
HKII from mitochondria (Fig. 6B), and compared to cells with
glucose present throughout (in which HKII remained mostly
associated with mitochondria). Preincubation in zero glucose
prolonged the t1/2 of glucose clearance from 102611 s to
210619 s (n = 7) (Fig. 7C2 and C4). This finding demonstrates
that the subcellular distribution of HKII strongly influences its
ability to promote anabolic use of glucose for glycogen synthesis.
Since Akt facilitates HK interaction with mitochondria [14], we
examined whether translocation of HKII from mitochondria to
cytoplasm in response to zero glucose pre-incubation was
suppressed by overexpression of constitutively activate Akt. With
Akt overexpression, the mixed pattern of mitochondria-bound and
cytosol-associated HKII-YFP did not change (Fig. 7A), and
prolongation of the t1/2 of glucose clearance by zero glucose
preincubation was abolished 107.069.5 s versus 210619 s (n = 8)
with and without Akt) (Fig. 7A and Fig. 7C3 and C4).
Thus, both glucose and Akt signaling promote the binding of
HKII to mitochondria, favoring glucose catabolism over glycogen
synthesis.
Figure 3. The time of exposure to extracellular glucose controls the rate of intracellular glucose clearance. Panel A illustrates how
exposure to 10 mM extracellular glucose for 75 s (1), 30 s (2) and 50 s (3) affects intracellular glucose clearance. In the 3 cases CytoB was applied for
15 s prior to removal of extracellular glucose. The 3 rates are compared in the right hand side panel and show that the final rate of glucose clearance
is similar in the 3 cases and that long exposure to extracellular glucose delays the clearance. In B a comparison of data obtained with 10 mM and
1 mM extracellular glucose show that application for up to two minutes of 1 mM glucose had no effect on the rate of intracellular glucose clearance,
demonstrating that intracellular glucose must reach a threshold to induce this effect. The right hand side panel shows again that the final rate of
glucose clearance measured in the presence of 10 mM glucose is similar to the maximum rate measure with 1 mM and the effect of high glucose is
thus to delay clearance.
doi:10.1371/journal.pone.0017674.g003
HK Localization and Glucose Fate
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Role of G-6-P in regulating HK activity and subcellular
distribution
We have hypothesized that HKII translocation to the cytosol
delays the t1/2 of glucose clearance when glucose is removed because
newly synthesized glycogen is mobilized and in the process keeps G-
6-P levels elevated, suppressing HK activity until glycogenolysis
ceases. We tested this hypothesis using both direct and indirect
approaches. First, in the presence of glucose, we applied iodoacetate
(IAA, 0.25 mM) to elevate G-6-P levels by inhibiting glycolysis. As
shown in Fig. 8A and C1, IAA caused translocation of HKII into the
cytosol, in the continued presence of 10 mM glucose, with a time
constant of 7.5 s (n= 10). This effect was fully reversible and HKII
re-associated with mitochondria with a time constant of 16 s (n=9)
following removal of IAA (Fig. 8C2). To rule out ATP depletion,
rather than G-6-P accumulation, as the cause of HKII translocation,
we also tested the mitochondrial uncoupler FCCP (5 mM) to deplete
mitochondrial ATP without elevating G-6-P levels. In 6 cells, FCCP
had no effect on HKII translocation (Fig. 8B). These data support
our hypothesis that the effect of glucose on HKII translocation and
inhibition is mediated via G-6-P.
To obtain further evidence that G-6-P causes dissociation of
HKs from mitochondria, we used permeabilized CHO cells
overexpressing HKI-YFP or HKII-YFP. Both HKI and HKII
spontaneously dissociated slowly from mitochondria when the
plasma membrane was permeabilized using 50 mM b escin (Fig. 9),
with time constants of 19.5 min (n= 6) and 17 min (n = 5)
(Fig. 9C), respectively although the difference was not significant.
Furthermore addition of 100 nM G-6-P at the time of cell
membrane permeabilization accelerated the rates of both HKI
and HKII dissociation (t=6.2 min (n = 4) for HKI and
t=5.5 min (n = 5) for HKII). Our data obtained with permeabi-
lized cells corroborate previous findings that G-6-P displaces both
HKI and HKII from isolated mitochondria [17]. However when
combined with our data obtained from intact cells, indicate that an
intracellular factor is present in intact cells that prevents the
dissociation of HKI induced by G-6-P in isolated mitochondria.
Importantly, our data suggest that, in the absence of any factor
other than G-6-P the two HKs have similar affinity for
mitochondrial membrane and dissociate at similar rates.
Finally, we directly measured intracellular G-6-P levels following
removal of 10 mM glucose in CHO cells transfected with GLUT1.
Upon removal of glucose, G-6-P levels remained elevated for about
,10 min and then decreased in a sigmoidal fashion with 50% decay
reached after ,15 min (Fig. 9C3 each data point in the graph
represents an average of 8 to 26 values). Together, these data
corroborate our glucose metabolismmeasurements, and support the
hypothesis that upon glucose removal G-6-P elevation inhibits
glucose phosphorylation by hexokinases. The decay in G-6-P that
follows, accounts for the gradual reactivation of hexokinase activity
and resumption of glucose phosphorylation.
Figure 4. Effects of GLUT1 overexpression on glycogen synthesis and breakdown in CHO cells. The rate of glycogen formation without
(A) and with (D) overexpression of GLUT1 and the rate of glycogen degradation (B) was studied using a protein targeted to glycogen linked to YFP
(PTG-YFP). In Panel A and D the cells were incubated in the absence of glucose for 2 to 3 hours prior to beginning cell imaging. This incubation in the
absence of glucose was carried out to deplete preformed glycogen. Without GLUT1 overexpression glycogen build up was slow, occurring over
several hours. This build up proceeded for up to 24 h filling almost completely the cell in some cases (C). With GLUT1 overexpression the rate of
glycogen synthesis increased and glycogen deposits could be observed 5 min after exposure to 10 mM glucose outside. It is interesting to note that
glycogen deposition occurred at least initially near the nucleus where mitochondria aggregate, suggesting that G-6-P generated by glycogen
degradation may be directly fed on to mitochondria.
doi:10.1371/journal.pone.0017674.g004
HK Localization and Glucose Fate
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Discussion
Catabolic and anabolic glucose utilization are both directed by
hexokinases, which channel G-6-P to glycolysis or glycogen and
lipid synthesis. While HKs coexist in many cell types, cells that
generate glycogen in response to insulin, such as adult muscle,
express primarily HKII, whereas cells that rely primarily on
glycolysis for energy production, such as the brain, express high
levels of HKI. The specificity of these enzymes is not related to
functional differences, since both phosphorylate glucose to G-6-P,
but may instead depend on subcellular location, reflecting spatial
compartmentalization of glucose metabolism. Thus, it has been
suggested that the association of HKI with mitochondria
channels glucose to the glycolytic pathway, whereas HKII, when
translocated to the cytoplasm, controls glycogen formation [9].
Our results using live cell imaging to track the subcellular
distributions of HKI and HKII provide direct support for this
hypothesis.
Glycogen breakdown generates G-6-P that inhibits HK
enzymatic activity
Our data show that HKI is strongly associated with mitochon-
dria, while HKII dynamically translocates between mitochondria
and the cytoplasm. This differential localization is associated with
a fast rate of glucose utilization upon removal of extracellular
glucose in cells expressing HKI, but inhibition of glucose
utilization in cells expressing high levels of HKII. We propose
that cytosolic HK II channel G-6-P towards the glycogen synthesis
pathway during exposure to 10 mM glucose, such that upon
glucose removal, mobilization of the newly-synthesized glycogen
regenerates G-6-P (or another glycolytic intermediate) which
inhibits HK activity. This phenomenon is primarily observed in
cells with cytosolic HKs that favor glycogen synthesis. In cells with
mitochondria-associated HKs, G-6-P is channeled towards the
glycolytic pathway and there is no G-6-P-induced inhibition. The
following evidence supports these hypotheses: 1) Conditions which
favor glycogen formation, such as PTG overexpression and long
exposure to glucose, enhances the duration of the inhibitory phase;
2) The effect of glucose is only observed with overexpression of
GLUT1 in CHO cells, which raises intracellular glucose enough to
rapidly stimulate glycogen synthesis. Indeed, only with overex-
pression of GLUT1 can glycogen synthesis be stimulated by
glucose within minutes. Without GLUT1 overexpression, signif-
icant glycogen synthesis requires more than 30 min of glucose
exposure and there is no HK inhibition upon glucose removal; 3)
Akt, which facilitates HKII interaction with mitochondria, reduces
the inhibitory phase and removal of glucose, which causes HKII
dissociation from mitochondria, enhances the inhibitory phase.
Figure 5. Overexpression of PTG delays glucose clearance. Panels A and B obtained with CHO cells overexpressing GLUT1 illustrate how
exogenous PTG delays glucose clearance. In both cases the cells were exposed to extracellular glucose for 50 s. Comparison of data in Panel B
(overexpressed GLUT1) and C (no GLUT1 overexpression) illustrate the lack of effect of exogenous PTG in the absence of GLUT1 overexpression,
supporting the hypothesis that GLUT1 is necessary for rapid build up of the glycogen store and inhibition of glucose utilization. Compilation of traces
in D illustrates once more that the final rate of glucose clearance is similar in all cases and that increased glycogen synthesis only delays glucose
utilization.
doi:10.1371/journal.pone.0017674.g005
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G-6-P regulates HK enzymatic activity as well as
subcellular localization
In HKI, the C terminal domain binds ATP and exhibits
catalytic activity, while the N terminal domain facilitates HK
interaction with the mitochondria outer membrane. Both domains
bind glucose and G-6-P synergistically. Binding of G-6-P to the C
and N terminal domains inhibits enzymatic activity and causes
dissociation from mitochondria either directly or via allosteric
interaction between the two domains. Pi prevents HKI inhibition
and dissociation by competing with G-6-P at the N terminal
domain [2,17,18,19,23,24,28]. On the other hand, Pi does not
bind to HKII and both the N- and C- domains exhibit catalytic
activity. We have shown that HKII dissociation from mitochon-
dria is insensitive to FCCP, which induces ATP depletion, but is
facilitated by the glycolytic inhibitor IAA, which elevates G-6-P.
These results indicate that the effect of glucose on HKII
translocation is mediated by G-6-P and not by ATP. Thus, ATP
regulates the catalytic activity of HKs, but not their association
with mitochondria. The lack of effect of glucose removal and IAA
on HKI association with mitochondria supports the hypothesis
that Pi competes with G-6-P to strengthen the interaction with
mitochondria. We have shown that upon plasma membrane
permeabilization, both HKI and HKII dissociate from mitochon-
dria with a time constant of approximately 20 min, which is
accelerated 4-fold by 100 nM G-6-P. These data are consistent
with results obtained with isolated mitochondria demonstrating
that G-6-P facilitates dissociation of both HKI and HKII from
mitochondria. Furthermore, our finding that HKI does not
dissociate from mitochondria upon glucose removal in intact cells
supports the hypothesis that an additional factor, perhaps Pi,
prevents the effect of G-6-P on HKI in intact cells.
Phosphorylation of residue T473 by Akt in the linker region
between the N and C terminal domain of HKII may facilitate its
interaction with mitochondria [14]. It has been proposed that this
effect of Akt requires the presence of glucose, based on the
observation that the protective effect of Akt against apoptosis,
which is mediated by HKs, requires glucose [13]. Our results
demonstrate that Akt does indeed regulate the interaction of HKII
with mitochondria, but its main effect is to prevent dissociation
from mitochondria upon glucose removal. To account for these
results, we suggest that Akt phosphorylates mitochondria-bound
HKII, thereby preventing the ability of G-6-P to reduce HK
mitochondrial interaction.
Physiological relevance of preferential expression of HKI
and HKII
In most native tissues such as muscle, liver and fat, hexokinases
coexist, but in muscle HKI is most abundant in fetal tissues, while
HKII represent 80% of total hexokinase activity in adult muscle
[3,4]. In adult muscle the increased expression of HKII is
Figure 6. Removal of glucose causes translocation of HKII, but not HKI, into the cytosol. Images in Panel A obtained with HKI-YFP
expressed in CHO cells show that removal of glucose did not affect HKI interaction with mitochondria. In contrast, HKII begun to dissociate from
mitochondria 5 min after glucose removal (B). Panel C shows the rates measured as ratio of fluorescence intensity obtained from intracellular
domains without and with mitochondria. In almost all cases the region without mitochondria was selected at the cell periphery and that with
mitochondria was selected near the nucleus. C1 is a comparison of the rates of HKI and HKII dissociation in response to glucose removal. C2 shows
the rate of HKII reassociation with mitochondria after glucose readdition.
doi:10.1371/journal.pone.0017674.g006
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associated with increased expression of GLUT4 and the
development of insulin sensitivity. In this context, HKII is both
cytosolic as well as bound to mitochondria. In light of our data,
it is interesting to speculate how this switch in HK and GLUT
affects glucose metabolism and cell function. In adult muscle
when extracellular glucose is high, for instance during a meal,
G-6-P is channeled towards both glycogen synthesis and
glycolysis, so that G-6-P levels remain low. However, between
meals, when extracellular glucose decreases and more impor-
tantly when insulin is no longer released by pancreatic b cells,
GLUT4 is internalized and intracellular glucose drops dramat-
ically. The ensuing G-6-P production resulting from glycogen
breakdown inhibits mitochondria-bound HKII-mediated glycol-
ysis within seconds. Elevated G-6-P also causes dissociation of
HKII from mitochondria further inhibiting glucose utilization.
G-6-P generated by glycogen breakdown is then channeled
through the glycolytic pathway to be further metabolized. In
contrast, in fetal tissue with high level of HKI and GLUT1
most HKs are bound to mitochondria and the low levels of
HKII found in the cytosol only generates little glycogen during
meals. Moreover, mitochondria-bound HKI being poorly
sensitive to G-6-P it follows that the low level of G-6-P
produced in between meals will have minimal effect on HK
activity and translocation. Finally, GLUT1 insertion into the
plasma membrane is not regulated by insulin, as a result glucose
uptake and intracellular glucose remain high even when blood
glucose decreases, further preventing glycogen degradation.
These properties ensure that glycolysis is the main source of
energy in these fetal tissues.
Such difference between HKI and HKII would not only affect
differentially glucose metabolism in fetal and adult muscle, but also
cell fate. There is a large body of evidence that mitochondria-
bound HKs protect against apoptosis via a direct interaction with
VDAC, which prevents the mitochondrial permeability transition
pore opening. Alternatively, the anti-apoptotic effect of mitochon-
dria-bound HKs may require glucose metabolism [12,29]. It
follows that during stress fetal cells preferentially expressing HKI
may cope better than adult cells expressing HKII as HKI remains
associated with mitochondria, thus maintaining glycolysis activity
and stability of VDAC in a low permeability state.
In summary, our data suggest that in cells that preferentially
express HKII and GLUT4, such as adult muscle, removal of
glucose causes the glycogen pathway to switch from synthesis to
degradation. The ensuing elevation of G-6-P inhibits and then
displaces HKII from mitochondria, causing the cell to switch from
glucose to glycogen utilization as a source of energy. In contrast, in
cells like neonatal muscle cells, which express preferentially HKI
and GLUT1, the strong association of HKI with mitochondria
implies that the cells primarily rely on glucose utilization as a
source of energy and glycogen has a minor role. In this case, the
strong association of HKI with mitochondria may also protect
against metabolic stress.
Figure 7. Constitutively active Akt prevents the effect of glucose removal on HKII dissociation from mitochondria. Images in (A)
obtained with overexpression of a constitutively active Akt illustrate how Akt prevents HKII dissociation evoked by removal of glucose. Panel B shows
a quantification of this effect, comparing the rate of HKII dissociation from mitochondria in response to glucose removal in the presence and absence
of exogenous Akt. Data in Panel C show how glucose clearance is affected by preincubation in the absence of glucose and how constitutively active
Akt prevents this effect. Previous data (Fig. 6B) have shown that HKII dissociates from mitochondria 15 to 30 min after removal of extracellular
glucose; comparison of traces C1 and C2 (in C2 cells were incubated for 30 min in the absence of glucose) indicates that this effect is accompanied by
a decrease in glucose clearance. Thus, glucose-induced HK dissociation slows the rate of glucose utilization. The recording in C3 obtained with cells
overexpressing constitutively active Akt indicates that Akt prevents the decrease in glucose clearance induced by incubation in the absence of
glucose for 30 min. This effect is very likely related to the effect of Akt on HKII translocation. The bar graph in C4 quantifies the effects of glucose
removal and Akt on glucose clearance.
doi:10.1371/journal.pone.0017674.g007
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Materials and Methods
Solutions and experimental techniques
The bath solution for cell imaging consisted of (in mM) 140
NaCl, 5 KCl, 1.1 MgCl2, 2.5 CaCl2, 10 HEPES, with the pH
adjusted to 7.2 with KOH. Glucose was added to this solution and
NMDG was added to maintain the solution’s osmolarity in the
absence of glucose. Solutions were perfused directly over the cells
using a gravity fed eight way perfusion device (Warner
Instruments, Hamden, CT) with electrically controlled solenoids
(The Lee Company, Westbrook, CT). Input and output of solution
volumes to the recording chamber (glass bottomed Petri dish) were
equilibrated to maintain constant flow rates and pressures within
the recording chamber. Experiments were carried out at room
temperature (25uC). Cytochalasin B (Cyto B) and other chemicals
were purchased from Sigma-Aldrich (St Louis, MO).
Molecular biology and cell culture
We obtained the FLIPglu-600 mM cDNA from Dr. W.B.
Frommer, GLUT from Dr. D. Abel, GLUT4-GFP from Dr. S.
Cushman, rat HKI and HKII from Dr. J. Wilson, PTG from
Dr. M Brady and GL-GFP and PTG-GFP from Dr. J. Guinovart.
Fusion of PTG or GL to mCherry was carried out by subcloning
into the mCherry N-1 vector. Constitutively active Akt was obtained
from Dr. W. Sellers (Addgene plasmid 9009). Fusion of rat HK’s to
YFP was accomplished by inserting a Bam H1 site at the last amino
acid of the coding sequence and subcloning into a modified pEYFPN-
1vector (Clontech, Mountain View, CA). The modified pEYFPN-1
carried the mutations Q86K and A206K. Similarly, GLUT1-GFP
was constructed by inserting a Kpn site at the last amino acid of the
coding sequence and subcloning into pEGFPN-1 vector (Clontech,
Mountain View, CA). All constructs were subcloned into the
mammalian expression vectors utilizing the CMV promoter. CHO
cells were transfected with 1 mg DNA plus 2.5 ml lipofectamine 2000
(Invitrogen, Carlsbad, CA) per 1.5 cm3 Petri dish. Expression of
FLIPglu-600 mM was sufficiently high after 24 h to perform FRET
experiments. Cells were cultured in DMEM high (25 mM) glucose
medium supplemented with 10% (v/v) fetal bovine serum (FBS),
penicillin (100 units/ml), streptomycin (100 units/ml) and 2 mM
glutamine and divided once a week by treatment with trypsin.
siRNA-mediated depletion and quantitative PCR
CHO cells (0.5–26106) were transfected with 30 to 40 nM
siRNAs using lipofectamine 2000 reagent (Invitrogen, Carlsbad
CA). Cells were used for experiments 2 days after transfection. The
sequences of siRNAs (DsRNA from IDT, San Diego, CA) were:
Figure 8. Rates of association and dissociation of HKI and HKII in response to glucose, IAA and FCCP. IAA, but not FCCP, facilitates HKII
dissociation from mitochondria. Images in Panel A obtained with HKII-YFP expressed in CHO cells show that addition of the glycolysis inhibitor, IAA,
in the presence of 10 mM glucose causes HKII dissociation from mitochondria within 5 to 15 min. In contrast, addition of FCCP, which depletes
mitochondrial ATP, had no effect on HKII interaction with mitochondria (B). These data indicate that G-6-P, rather than ATP mediates the effect of
glucose removal on HKII translocation. Panel C shows the rates measured as ratio of fluorescence intensity obtained from intracellular domains
without and with mitochondria. C1 is a comparison of the rates of HKII dissociation from mitochondria in response to IAA and FCCP addition in the
presence of 10 mM glucose outside. C2 illustrates the rate of reassociation HKII with mitochondria upon removal of IAA.
doi:10.1371/journal.pone.0017674.g008
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HKI AACGTGAATCCCACAGGTAACTTCTTG and CG-
GATGTCTTCTAATGATCCATCGTC
HKII GTATCCAATTCAATAGTTACATCCCTC and CTT-
TGGTTTCCTTTGCTTAACATCCCA
RT–PCR analysis. Purified RNA from CHO cells (2–86106) was
isolated using the RNAeasy Kit (Qiagen, Valencia, CA). First-strand
cDNA synthesis was primed with oligo (dT) (Superscript III kit,
Invitrogen, Carlsbad, CA). Real-time PCR was performed using an
iCycler IQ5 (Bio-Rad, Hercules, CA) with the iQ SYBR Green
Supermix (Bio-Rad, Hercules, CA). The cDNA levels were
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
or actin. Values shown in Supplementary Table S1 are CT test – CT
GAPDH. Sequences of the primers were:
HKI GAAGAATGGCCTCTCCCGGG and GCCATGCAC-
GATGTTCTCTGG
HKII AGAGCATCCTCCTCAAGTGGAC and ACCAAGT-
GCAGAAGGTTGACCA
GAPDH GCGCCAGCATCACCCCATTTGATG and GGT-
CGGCGTGAACGGATTTGGCCG
Actin TGGCATCCACGAAACTACAT AND TGGTACCA-
CCAGACAGCACT
Cell membrane permeabilization
The cells were permeabilized with 50 mM b-escin dissolved in
an intracellular-type solution containing 140 mM KCl, 5 mM
NaCl, 0.5 mM MgCl2, 100 nM Ca
2+, 5 mM glucose and 1 mM
DTT. To monitor cell membrane permeabilization we expressed
the fluorophore CFP together with HKx-YFP. After exposure to
b-escin for about 45 s CFP leaked slowly out of the cell over a
period of 30 to 45 min, indicating cell membrane permeabilzation.
At the same time HKs begun to slowly dissociate from
mitochondria.
FRET imaging
All cells were imaged live without fixation. Images (16-bit) were
acquired using a Nikon Eclipse TE300 microscope fitted with a
606 (N.A. 1.4) oil immersion lens (Nikon, Melville, NY) and
equipped with a filter cube comprising a CFP bandpass excitation
filter: 436/20b, together with a longpass dichroic mirror:
455DCLP (Chroma Technology Corp, Rockingham, VT). LED’s
(Lumileds; San Jose, CA) were used as light sources: one emitting
at 455620 nm (royal blue) and the other emitting at 505615 nm
(cyan). LED’s and camera exposure were controlled by MetaFluor
Imaging 6.1 software (Molecular Devices Corp., Sunnyvale, CA).
Ratiometric FRET measurements were performed by simulta-
neously monitoring CFP and YFP emissions of the sample when
excited at the wavelengths for CFP (royal blue LED), as described
previously [26]. The ratio between YFP and CFP emission were
measured online in real time using MetaFluor Imaging software.
For analysis, background light intensity was subtracted from the
individual YFP and CFP emission. YFP and CFP images were
acquired simultaneously using a Dual View image splitter (Optical
Insights, Tucson, AZ) equipped with a 505 nm long-pass dichroic
filter to separate the CFP and YFP signals, a CFP emission filter
Figure 9. HKs dissociation frommitochondria in permeabilized cells. Panels A and B illustrate the spontaneous dissociation of HKI-YFP in the
absence and presence of G-6-P, respectively, after cell membrane permeabilization with 50 mM b-escin. Panel C1 and C2 show that HKI and HKII
dissociate for mitochondria at very similar rates, and G-6-P increases these rates by approximately 4 fold (20 min vs. 5 min). The triangles represent
measurements obtained with G-6-P (100 nM) and the circles are for values obtained in the absence of G-6-P. Panel C3 shows the change in
intracellular G-6-P levels following glucose removal.
doi:10.1371/journal.pone.0017674.g009
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(480/30) and a YFP emission filter (535/40). Superposition of the
CFP and YFP images was carried out using the imaging software.
Images were captured with a Cascade 512B digital camera
(Photometrics, Tucson, AZ). Exposure times were optimized in
each case but varied between 300–500 ms and were recorded at a
constant rate for each cell between 0.2–0.33 Hz. Many experi-
ments lasted more than one hour leading to a slow drift in the
FRET ratio baseline in some cases. In most figures an initial drift
in FRET ratio was corrected using exponential curve fitting.
In most cases changes in the FRET ratio measured upon
addition of glucose could be fitted to a single exponential. FRET
ratio recovery following glucose removal could not be fitted to a
single exponential due to a lag in glucose clearance following
removal of extracellular glucose. In this case the rate of glucose
clearance was satisfactorily fitted to a sigmoidal function y= y0+a/
1+e2(x0/s), where60, an estimate of the time requires to reach
half of the change in FRET ratio, accounts for the lag period,
while s, an estimate of the rate of change is more or less
independent of the lag period.
Translocation imaging of HKs between mitochondria and
cytoplasm was quantified as ratio of light intensity between two
intracellular regions of interest with and without a high
concentration of mitochondria. Background light was subtracted
in both cases. Images were acquired using an Olympus IX70
inverted microscope (Olympus America Inc., Center Valley, PA)
fitted with an Olympus plan apo 660. 1.4 N.A. oil immersion
objective and a cooled CCD camera (Model Quantix, Photo-
metrics, Tucson, AZ). Imaging Workbench software was used for
data acquisition and analysis. YFP (XF104-2) and CFP (XF130-2)
filter cubes were purchased from Omega Optical Inc. (Brattleboro,
VT).
Glucose-6-Phosphate assay
We used a commercial G-6-P assay kit (Biovision Research
Products, Mountain View, CA). CHO cells (0.5–26106) were
transfected with GLUT1 (,3 mg). Two days later cells were
washed in ice cold PBS and frozen in situ in dryice ethanol. 200 ml
of 6% (v/v) perchloric acid added and the cells scraped while
frozen. Cells were homogenized via a ‘‘Qiashredder’’ column at
4uC and the homogenate neutralized with 500 mM ethanolamine
and 10 M KOH [30]. Samples were then centrifuged to remove
insoluble material (10 mins 15000 g 4uC) 50 ml samples were
transferred into wells of a 96-well plate and brought to a volume of
100 ml with assay buffer. Absorbance at 450 nm was measured,
using a POLARstar Omega microplate reader (BMG LABTECH
GmbH, Offenburg/Germany). Background samples (without
enzyme mix) were introduced to estimate the NADH/NADPH
levels prior to G-6-P conversion. Finally, to estimate the G-6-P
levels a curve was generated with G-6-P standards containing 0, 2,
4, 6, 8, 10, 20 nmol/well.
Supporting Information
Figure S1 Subcellular distribution of HKI linked to YFP
in CHO cells. To investigate the subcellular localization of HK
in CHO cells we co-expressed HKI-CFP (A) together with the
mitochondria marker MitoTracker-YFP (B). In panel C superim-
position of the two images shows that the localization of HKI and
MitoTracker overlap, indicating HKI association with mitochon-
dria.
(TIF)
Figure S2 Glucose uptake and clearance in CHO cells
over expressing GLUT1 and GLUT4. To monitor GLUT
insertion into the plasma membrane, we used constructs of
GLUT1 and GLUT4 linked to GFP. In both cases, there was only
faint GFP fluorescence detected in the plasma membrane, with
most of the fluorescence associated with intracellular membrane
compartments (results not shown). However, as shown in Panels B
and C, even this low level of plasma membrane GLUT insertion
had dramatic effects on glucose transport. With GLUT1 over
expression, the rate of glucose entry, illustrated by a decrease in
FRET ratio, increased dramatically, with the time constant t
dropping from 34.5+/25 s (n = 7) to 1.9+/20.6 s (n = 8) (Panels 1
and 3). The rate of glucose clearance, indicated by an increase in
FRET ratio also increased, with a t1/2 approaching 10 s (9.8+/
23.5 s). With GLUT4 over expression, the rate of glucose uptake
decreased by almost 14-fold, from 34.5 s to 2.5 s (Panels 1 and 5).
The rate of glucose clearance also increased in this case, although
to a lesser level than with GLUT1, the time to reach half clearance
(t1/2) being around 12.5+/26.5 s (n = 7). In panels 1, 3 and 5 the
rate of glucose uptake was fitted to an exponential decay, in panels
2, 4 and 6 glucose clearance was fitted to a sigmoidal function (see
Materials and Methods for details). These data suggest that
increased insertion of GLUTs in the plasma membrane increase
both glucose influx and efflux.
(TIF)
Figure S3 Effects of GLUT1 on glucose utilization in the
presence of Cyto B in CHO cells. Panel A shows data
obtained with a CHO cell exposed to Cyto B (20 mM) in the
continuous presence of 10 mM glucose. The right hand side plots
show the rate of glucose clearance following removal of glucose in
the absence of Cyto B (A1) and in the presence of Cyto B (B1). The
closeness of the two ts suggests that, with cells exhibiting a slow
glucose uptake phenotype, GLUT-mediated glucose efflux has
little effect in glucose clearance. This trace also illustrates that the
effect of Cyto B is readily reversible, as glucose entry resumed,
albeit at a lower rate, 30 s after Cyto B removal. In B data were
obtained with a CHO cell transfected with GLUT1, which
exhibited a high rate of glucose uptake. In this case, Cyto B
dramatically reduced the rate of clearance as compared to that
recorded in the absence of Cyto B and after outside glucose
removal (plots B3 and B4). These data suggest that GLUT-
mediated efflux plays a role in glucose clearance in cells
overloaded with glucose.
(TIF)
Figure S4 siRNA-mediated depletion of HKI and HKII.
To study the role of HKs in glucose clearance we transfected
CHO cells with 30 to 40 nM of HKI or HKII siRNA. (A)
Inhibition of HKI expression caused a decrease in the rate of
glucose clearance with the time to reach half clearance (t1/2)
increasing from 75+/215 s to 135+/222 s (n = 9). (B) Similarly,
inhibition of HKII expression decreased glucose clearance with t1/
2 reaching 152+/220 s (n = 9). These results indicate that
endogenous HKI and HKII equally contribute to glucose
clearance in CHO cells. The data obtained with RT-PCR
corroborate this result and show that the levels of endogenous
HKI and HKII are very similar in these cells.
(TIF)
Table S1 Quantification of HKI and HKII levels in CHO
cells.We have used the RT-PCR method to estimate the levels of
HKI and HKII in native cells and in cells over expressing HKI
and HKII. Our results indicate that the level of these two enzymes
is similar. This is consistent with our observation where depletion
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of endogenous HKI and HKII decrease glucose clearance to
similar extend. This quantitative analysis also shows that cell
culture in the absence of glucose causes a slight increase in HK
levels. This is important when considering the effect of glucose
removal on glucose utilization. Indeed, we have shown that
incubation in the absence of glucose decreases glucose clearance
and we hypothesized that this effect was related to HK
translocation away from mitochondria. Our quantitative analysis
supports this hypothesis and shows that the effect on glucose
clearance is not due to a decrease in HK level. Finally, we show, as
expected, that over expression of HKs is accompanied by an
increased level of intracellular HK. Thus, the decrease in glucose
clearance observed with HKII over expression may be related to
increased level of the enzyme in the cytoplasm, favoring glycogen
synthesis.
(DOC)
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